{"gene":"TFB2M","run_date":"2026-04-28T21:42:59","timeline":{"discoveries":[{"year":2010,"finding":"In a reconstituted in vitro transcription system, TFAM and TFB2M are the only two essential initiation factors required to drive transcription from LSP and HSP1 promoters of the mitochondrial genome; together they increase transcription efficiency 100-200-fold compared to RNA polymerase alone. TFB1M (the paralog) showed no significant transcription activity in this system, confirming TFB2M as the bona fide transcription factor.","method":"Recombinant in vitro transcription reconstitution with purified proteins","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro system with defined components, paralog comparison as control","pmids":["20410300"],"is_preprint":false},{"year":2005,"finding":"Expression of TFB2M (and TFB1M) is governed by nuclear respiratory factors NRF-1 and NRF-2, and NRF recognition sites within the TFB2M promoter are required for maximal transactivation by PGC-1alpha and PRC coactivators, placing TFB2M downstream of a nuclear biogenesis program.","method":"Promoter-reporter assays, site-directed mutagenesis of NRF sites, ectopic PGC-1alpha expression","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — promoter mutagenesis combined with ectopic expression in cellular systems, replicated across multiple coactivators","pmids":["15684387"],"is_preprint":false},{"year":2016,"finding":"TFAM and TFB2M work synergistically to melt the LSP promoter from -4 to +1 in the open complex; neither POLRMT+TFB2M nor POLRMT+TFAM alone can efficiently melt the promoter. POLRMT+TFB2M can produce 2-mer abortive RNAs but longer RNAs require TFAM, indicating TFAM has post-recruitment roles in stabilizing the open complex.","method":"2-aminopurine fluorescence mapping of promoter melting, equilibrium binding (Kd measurements), abortive RNA synthesis assays","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal in vitro methods (2-AP mapping, fluorescence binding, abortive transcription) in a single study","pmids":["27903899"],"is_preprint":false},{"year":2020,"finding":"The C-terminal tail (C-tail) of TFB2M constitutes an autoinhibitory mechanism that reduces its DNA binding affinity; deletion of the C-tail greatly increases DNA binding. RNA polymerase (POLRMT) relieves this autoinhibition by interacting with the C-tail and engaging it in complex formation, thereby enabling specific assembly of the transcription initiation complex.","method":"Fluorescence anisotropy DNA binding titrations with C-tail deletion mutants; structural analysis of available TFB2M crystal structures","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1/2 — quantitative binding assays with deletion mutants plus structural analysis, mechanistic model supported by two orthogonal approaches","pmids":["32241911"],"is_preprint":false},{"year":2021,"finding":"TFB2M (and POLRMT) are indispensable for the maintenance of human mtDNA; knockout of TFB2M results in complete mtDNA loss, and this loss cannot be rescued by TFB1M, demonstrating TFB2M's non-redundant role in priming both strand-asynchronous and strand-coupled mtDNA replication.","method":"CRISPR/knockout of TFB2M and POLRMT in human cybrid cells; 2D agarose gel electrophoresis of replication intermediates","journal":"Biochimica et biophysica acta. Molecular cell research","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined molecular phenotype (complete mtDNA loss), paralog rescue experiment as control","pmids":["34744028"],"is_preprint":false},{"year":2010,"finding":"TFAM and TFB2M localize to the nucleus of cardiac myocytes and bind directly to the Serca2 gene promoter (at -122 to -117 nt for TFB2M), regulating nuclear gene transcription; mutation of these binding sites decreases Serca2 transcription.","method":"Immunostaining (nuclear localization), chromatin immunoprecipitation (ChIP), fluorescence correlation spectroscopy, promoter mutation/reporter assays","journal":"Cardiovascular research","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP plus functional promoter mutagenesis, single lab study","pmids":["21113058"],"is_preprint":false},{"year":2018,"finding":"A gain-of-function variant TFB2M His264Tyr (c.790C>T) increases mitochondrial gene transcription and mitochondrial function (ATP production, membrane potential, oxygen consumption, ROS) beyond wild-type TFB2M levels; molecular dynamics simulation suggests the variant increases rigidity in the hinge region, potentially altering DNA loading/unloading.","method":"Overexpression of variant vs. wild-type TFB2M in patient fibroblasts; functional mitochondrial assays; molecular dynamics simulation","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2/3 — functional gain-of-function assay in primary cells plus computational modeling, single lab","pmids":["30414672"],"is_preprint":false},{"year":2025,"finding":"Cryo-EM structures of human mitochondrial transcription initiation complexes (IC3 and slipped-IC3) reveal that TFB2M recognizes the non-template strand via a non-template stabilizing loop (K153LDPRSGGVIKPP165) and Y209, contacting the (-1)AAA(+2) non-template sequence; TFB2M interactions with the non-template strand stabilize the transcription bubble and the -1 non-template adenine is engaged by TFB2M to facilitate initiation from +1. TFB2M is subsequently released as elongation proceeds.","method":"Cryo-EM structural determination of active initiation complexes with resolved transcription bubbles and RNA transcripts","journal":"bioRxiv","confidence":"High","confidence_rationale":"Tier 1 — cryo-EM structures of active complexes with atomic detail of TFB2M-DNA contacts","pmids":["bio_10.1101_2024.12.02.626445"],"is_preprint":true},{"year":2025,"finding":"Cryo-EM structures capturing the transition from open promoter complex to processive elongation complex reveal that TFB2M is sequentially released as the transcription complex transitions to elongation, and show new determinants of promoter specificity involving TFB2M.","method":"Cryo-EM structural series capturing multiple stages of mitochondrial transcription","journal":"bioRxiv","confidence":"High","confidence_rationale":"Tier 1 — series of cryo-EM structures capturing dynamic transitions in TFB2M engagement and release","pmids":["bio_10.1101_2025.04.03.647028"],"is_preprint":true},{"year":2025,"finding":"Knockdown of TFB2M in lung adenocarcinoma cells induces ferroptosis via a mitophagy-dependent mechanism: loss of TFB2M activates mitophagy, which degrades GPX4 (localized to mitochondria), leading to lipid peroxide accumulation and ferroptotic cell death; this was reversed by the mitophagy inhibitor Mdivi-1.","method":"siRNA knockdown, Western blot of ferroptosis/mitophagy markers, immunofluorescence co-localization of GPX4 with TOM20, ROS/lipid peroxide/Fe2+ measurements, xenograft mouse model with mitophagy inhibitor","journal":"Expert review of anticancer therapy","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function with multiple orthogonal readouts and inhibitor rescue, single lab","pmids":["40878482"],"is_preprint":false}],"current_model":"TFB2M is an essential mitochondrial transcription initiation factor that assembles with POLRMT and TFAM on mtDNA promoters (LSP and HSP1): its non-template strand-stabilizing loop and Y209 residue contact the non-template DNA to melt the promoter from -4 to +1, while its C-terminal tail autoinhibits DNA binding until POLRMT interaction relieves this inhibition; TFB2M is non-redundant with its paralog TFB1M, is required for mtDNA maintenance (loss causes complete mtDNA depletion), and is released upon transition to processive elongation."},"narrative":{"teleology":[{"year":2005,"claim":"Before TFB2M's upstream regulation was defined, it was unknown how its expression was coordinated with mitochondrial biogenesis; promoter analysis revealed that NRF-1, NRF-2, and PGC-1α/PRC coactivators directly govern TFB2M transcription, placing it within the nuclear biogenesis program.","evidence":"Promoter-reporter assays with NRF site mutagenesis and ectopic PGC-1α expression in mammalian cells","pmids":["15684387"],"confidence":"High","gaps":["Whether post-transcriptional regulation also tunes TFB2M protein levels","How TFB2M expression responds to metabolic stress signals beyond PGC-1α"]},{"year":2010,"claim":"Although two TFB paralogs existed, it was unclear which was the bona fide transcription factor; reconstituted in vitro transcription demonstrated that TFB2M (not TFB1M) is the essential initiation factor that, with TFAM, increases transcription 100–200-fold from LSP and HSP1.","evidence":"Recombinant in vitro transcription with purified POLRMT, TFAM, TFB2M, and TFB1M","pmids":["20410300"],"confidence":"High","gaps":["The molecular basis for TFB1M's transcriptional inactivity despite structural similarity","Whether TFB2M has additional roles beyond promoter-dependent initiation"]},{"year":2010,"claim":"TFB2M was assumed to function exclusively in mitochondria; ChIP and promoter mutagenesis showed that TFB2M also localizes to the nucleus in cardiac myocytes and binds the Serca2 nuclear gene promoter to regulate its transcription.","evidence":"Immunostaining, ChIP, fluorescence correlation spectroscopy, and promoter mutation/reporter assays in cardiomyocytes","pmids":["21113058"],"confidence":"Medium","gaps":["Whether nuclear TFB2M regulates genes beyond Serca2","The mechanism of TFB2M nuclear import","Independent replication in non-cardiac cell types"]},{"year":2016,"claim":"It was unknown how the promoter was physically opened; 2-aminopurine fluorescence mapping showed that TFB2M and TFAM synergistically melt the LSP promoter from -4 to +1, with neither factor alone sufficient for full open complex formation.","evidence":"2-aminopurine fluorescence, equilibrium binding (Kd), and abortive transcription assays on reconstituted complexes","pmids":["27903899"],"confidence":"High","gaps":["Atomic details of TFB2M contacts with the melted non-template strand","Whether the melting mechanism differs at HSP1 versus LSP"]},{"year":2018,"claim":"A gain-of-function TFB2M variant (H264Y) demonstrated that increased TFB2M activity enhances mitochondrial gene transcription, ATP production, and oxygen consumption, linking TFB2M activity levels to mitochondrial output.","evidence":"Overexpression of H264Y versus wild-type TFB2M in patient fibroblasts with functional mitochondrial assays and molecular dynamics simulation","pmids":["30414672"],"confidence":"Medium","gaps":["Whether H264Y alters promoter melting kinetics specifically","Whether other naturally occurring TFB2M variants similarly affect mitochondrial function","Single-lab finding without independent replication"]},{"year":2020,"claim":"How TFB2M avoids premature DNA engagement was unknown; deletion mutagenesis revealed that the C-terminal tail autoinhibits DNA binding, and POLRMT relieves this autoinhibition upon complex formation, providing an ordered assembly mechanism.","evidence":"Fluorescence anisotropy DNA binding titrations with C-tail deletion mutants and structural analysis","pmids":["32241911"],"confidence":"High","gaps":["The precise POLRMT-C-tail interface at atomic resolution","Whether the autoinhibitory mechanism is conserved in TFB1M"]},{"year":2021,"claim":"Whether TFB2M is required for mtDNA maintenance (beyond transcription) was unresolved; CRISPR knockout showed that TFB2M loss causes complete mtDNA depletion, confirming its non-redundant role in priming both modes of mtDNA replication.","evidence":"CRISPR knockout of TFB2M in human cybrid cells; 2D agarose gel electrophoresis of replication intermediates","pmids":["34744028"],"confidence":"High","gaps":["Which specific replication primer(s) require TFB2M-initiated transcripts","Whether partial TFB2M depletion produces intermediate mtDNA copy number phenotypes"]},{"year":2025,"claim":"Cryo-EM structures resolved the atomic contacts by which TFB2M stabilizes the transcription bubble: a non-template stabilizing loop (K153–P165) and Y209 engage the non-template strand, and TFB2M is released upon transition to processive elongation.","evidence":"Cryo-EM of human mitochondrial initiation complexes (IC3, slipped-IC3) and elongation transition series (preprint)","pmids":["bio_10.1101_2024.12.02.626445","bio_10.1101_2025.04.03.647028"],"confidence":"High","gaps":["Structures are preprints awaiting peer review","Functional validation of individual loop residue contributions by mutagenesis","Whether TFB2M release is actively triggered or passive"]},{"year":2025,"claim":"TFB2M depletion in cancer cells was shown to trigger ferroptosis through mitophagy-dependent degradation of GPX4, revealing an unexpected link between mitochondrial transcription loss and regulated cell death.","evidence":"siRNA knockdown in lung adenocarcinoma cells with ferroptosis/mitophagy markers, GPX4 co-localization, and xenograft rescue with Mdivi-1","pmids":["40878482"],"confidence":"Medium","gaps":["Whether ferroptosis is a direct consequence of mtDNA loss or a specific TFB2M function","Independent replication in additional cancer types","Whether the GPX4 degradation mechanism generalizes beyond lung adenocarcinoma"]},{"year":null,"claim":"Key open questions include the precise mechanism by which TFB2M is released during the initiation-to-elongation transition, whether TFB2M has functions beyond transcription initiation (e.g., in nuclear gene regulation), and how TFB2M variants contribute to human mitochondrial disease.","evidence":"","pmids":[],"confidence":"Low","gaps":["No causative Mendelian disease mutation in TFB2M has been reported","The structural basis for HSP1-versus-LSP promoter specificity by TFB2M is not fully resolved","Whether partial TFB2M deficiency produces disease phenotypes distinct from complete mtDNA depletion"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,2,3,5,7]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,2,5,6]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,2,4,6,7]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[5]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,2,6,7]},{"term_id":"R-HSA-69306","term_label":"DNA Replication","supporting_discovery_ids":[4]},{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[1,4]}],"complexes":["Mitochondrial transcription initiation complex (POLRMT–TFAM–TFB2M)"],"partners":["POLRMT","TFAM"],"other_free_text":[]},"mechanistic_narrative":"TFB2M is an essential mitochondrial transcription initiation factor that, together with TFAM and POLRMT, drives transcription from the LSP and HSP1 promoters of the mitochondrial genome [PMID:20410300]. TFB2M cooperates with TFAM to melt the promoter from positions -4 to +1, stabilizing the open complex via a non-template strand-stabilizing loop (K153–P165) and residue Y209 that contact the non-template DNA; its C-terminal tail autoinhibits DNA binding until relieved by interaction with POLRMT, ensuring ordered initiation complex assembly [PMID:27903899, PMID:32241911]. TFB2M is non-redundant with its paralog TFB1M: knockout causes complete mtDNA depletion, establishing that TFB2M-dependent transcription is required for priming both strand-asynchronous and strand-coupled mtDNA replication [PMID:34744028]. TFB2M expression is controlled by NRF-1/NRF-2 and the PGC-1α coactivator, linking it to the nuclear mitochondrial biogenesis program [PMID:15684387]."},"prefetch_data":{"uniprot":{"accession":"Q9H5Q4","full_name":"Dimethyladenosine transferase 2, mitochondrial","aliases":["Hepatitis C virus NS5A-transactivated protein 5","HCV NS5A-transactivated protein 5","Mitochondrial 12S rRNA dimethylase 2","Mitochondrial transcription factor B2","h-mtTFB","h-mtTFB2","hTFB2M","mtTFB2","S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 2"],"length_aa":396,"mass_kda":45.3,"function":"S-adenosyl-L-methionine-dependent rRNA methyltransferase which may methylate two specific adjacent adenosines in the loop of a conserved hairpin near the 3'-end of 12S mitochondrial rRNA (Probable). Component of the mitochondrial transcription initiation complex, composed at least of TFB2M, TFAM and POLRMT that is required for basal transcription of mitochondrial DNA (PubMed:12068295, PubMed:15526033, PubMed:20410300, PubMed:29149603). In this complex, TFAM recruits POLRMT to a specific promoter whereas TFB2M induces structural changes in POLRMT to enable promoter opening and trapping of the DNA non-template strand (PubMed:15526033, PubMed:29149603). Stimulates transcription independently of the methyltransferase activity (PubMed:12897151)","subcellular_location":"Mitochondrion","url":"https://www.uniprot.org/uniprotkb/Q9H5Q4/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/TFB2M","classification":"Common Essential","n_dependent_lines":877,"n_total_lines":1208,"dependency_fraction":0.7259933774834437},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TFB2M","total_profiled":1310},"omim":[{"mim_id":"607055","title":"TRANSCRIPTION FACTOR B2, MITOCHONDRIAL; TFB2M","url":"https://www.omim.org/entry/607055"},{"mim_id":"607033","title":"TRANSCRIPTION FACTOR B1, MITOCHONDRIAL; TFB1M","url":"https://www.omim.org/entry/607033"},{"mim_id":"601778","title":"POLYMERASE, RNA, MITOCHONDRIAL; POLRMT","url":"https://www.omim.org/entry/601778"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Mitochondria","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TFB2M"},"hgnc":{"alias_symbol":["FLJ23182","FLJ22661","Hkp1"],"prev_symbol":[]},"alphafold":{"accession":"Q9H5Q4","domains":[{"cath_id":"3.40.50.150","chopping":"73-279_290-304","consensus_level":"high","plddt":90.0947,"start":73,"end":304},{"cath_id":"1.10.8.100","chopping":"317-380","consensus_level":"high","plddt":96.1662,"start":317,"end":380}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H5Q4","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H5Q4-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H5Q4-F1-predicted_aligned_error_v6.png","plddt_mean":80.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TFB2M","jax_strain_url":"https://www.jax.org/strain/search?query=TFB2M"},"sequence":{"accession":"Q9H5Q4","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9H5Q4.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9H5Q4/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H5Q4"}},"corpus_meta":[{"pmid":"15684387","id":"PMC_15684387","title":"Control of mitochondrial transcription specificity factors (TFB1M and TFB2M) by nuclear respiratory factors (NRF-1 and NRF-2) and PGC-1 family coactivators.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15684387","citation_count":552,"is_preprint":false},{"pmid":"20410300","id":"PMC_20410300","title":"Human mitochondrial transcription revisited: only TFAM and TFB2M are required for transcription of the mitochondrial genes in vitro.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20410300","citation_count":162,"is_preprint":false},{"pmid":"27903899","id":"PMC_27903899","title":"Human mitochondrial transcription factors TFAM and TFB2M work synergistically in promoter melting during transcription initiation.","date":"2016","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/27903899","citation_count":69,"is_preprint":false},{"pmid":"21113058","id":"PMC_21113058","title":"Mitochondrial transcription factors TFAM and TFB2M regulate Serca2 gene transcription.","date":"2010","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/21113058","citation_count":45,"is_preprint":false},{"pmid":"20643228","id":"PMC_20643228","title":"Mitochondrial DNA depletion and its correlation with TFAM, TFB1M, TFB2M and POLG in human diffusely infiltrating astrocytomas.","date":"2010","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/20643228","citation_count":42,"is_preprint":false},{"pmid":"32174027","id":"PMC_32174027","title":"Over-expression of TFB2M facilitates cell growth and metastasis via activating ROS-Akt-NF-κB signalling in hepatocellular carcinoma.","date":"2020","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/32174027","citation_count":22,"is_preprint":false},{"pmid":"34744028","id":"PMC_34744028","title":"TFB2M and POLRMT are essential for mammalian mitochondrial DNA replication.","date":"2021","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/34744028","citation_count":19,"is_preprint":false},{"pmid":"33982328","id":"PMC_33982328","title":"TFB2M activates aerobic glycolysis in hepatocellular carcinoma cells through the NAD+ /SIRT3/HIF-1α signaling.","date":"2021","source":"Journal of gastroenterology and hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/33982328","citation_count":12,"is_preprint":false},{"pmid":"32241911","id":"PMC_32241911","title":"The C-terminal tails of the mitochondrial transcription factors Mtf1 and TFB2M are part of an autoinhibitory mechanism that regulates DNA binding.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32241911","citation_count":8,"is_preprint":false},{"pmid":"30414672","id":"PMC_30414672","title":"Identification of a rare homozygous c.790C>T variation in the TFB2M gene in Korean patients with autism spectrum disorder.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30414672","citation_count":8,"is_preprint":false},{"pmid":"38094251","id":"PMC_38094251","title":"Expression and Purification of Recombinant Human Mitochondrial RNA Polymerase (POLRMT) and the Initiation Factors TFAM and TFB2M.","date":"2023","source":"Bio-protocol","url":"https://pubmed.ncbi.nlm.nih.gov/38094251","citation_count":8,"is_preprint":false},{"pmid":"18980857","id":"PMC_18980857","title":"Mutational screening of the mitochondrial transcription factors B1 and B2 (TFB1M and TFB2M) in Parkinson's disease.","date":"2008","source":"Parkinsonism & related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/18980857","citation_count":5,"is_preprint":false},{"pmid":"40878482","id":"PMC_40878482","title":"Knockdown of TFB2M induces ferroptosis in lung adenocarcinoma via mitophagy-mediated GPX4 degradation.","date":"2025","source":"Expert review of anticancer therapy","url":"https://pubmed.ncbi.nlm.nih.gov/40878482","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.04.03.647028","title":"Structural Basis for Promoter Recognition and Transcription Factor Binding and Release in Human Mitochondria","date":"2025-04-04","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.03.647028","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.12.02.626445","title":"Human mitochondrial RNA polymerase structures reveal transcription start-site and slippage mechanism","date":"2024-12-02","source":"bioRxiv","url":"https://doi.org/10.1101/2024.12.02.626445","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8609,"output_tokens":2512,"usd":0.031753},"stage2":{"model":"claude-opus-4-6","input_tokens":5820,"output_tokens":2656,"usd":0.14325},"total_usd":0.175003,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2010,\n      \"finding\": \"In a reconstituted in vitro transcription system, TFAM and TFB2M are the only two essential initiation factors required to drive transcription from LSP and HSP1 promoters of the mitochondrial genome; together they increase transcription efficiency 100-200-fold compared to RNA polymerase alone. TFB1M (the paralog) showed no significant transcription activity in this system, confirming TFB2M as the bona fide transcription factor.\",\n      \"method\": \"Recombinant in vitro transcription reconstitution with purified proteins\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro system with defined components, paralog comparison as control\",\n      \"pmids\": [\"20410300\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Expression of TFB2M (and TFB1M) is governed by nuclear respiratory factors NRF-1 and NRF-2, and NRF recognition sites within the TFB2M promoter are required for maximal transactivation by PGC-1alpha and PRC coactivators, placing TFB2M downstream of a nuclear biogenesis program.\",\n      \"method\": \"Promoter-reporter assays, site-directed mutagenesis of NRF sites, ectopic PGC-1alpha expression\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — promoter mutagenesis combined with ectopic expression in cellular systems, replicated across multiple coactivators\",\n      \"pmids\": [\"15684387\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TFAM and TFB2M work synergistically to melt the LSP promoter from -4 to +1 in the open complex; neither POLRMT+TFB2M nor POLRMT+TFAM alone can efficiently melt the promoter. POLRMT+TFB2M can produce 2-mer abortive RNAs but longer RNAs require TFAM, indicating TFAM has post-recruitment roles in stabilizing the open complex.\",\n      \"method\": \"2-aminopurine fluorescence mapping of promoter melting, equilibrium binding (Kd measurements), abortive RNA synthesis assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal in vitro methods (2-AP mapping, fluorescence binding, abortive transcription) in a single study\",\n      \"pmids\": [\"27903899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The C-terminal tail (C-tail) of TFB2M constitutes an autoinhibitory mechanism that reduces its DNA binding affinity; deletion of the C-tail greatly increases DNA binding. RNA polymerase (POLRMT) relieves this autoinhibition by interacting with the C-tail and engaging it in complex formation, thereby enabling specific assembly of the transcription initiation complex.\",\n      \"method\": \"Fluorescence anisotropy DNA binding titrations with C-tail deletion mutants; structural analysis of available TFB2M crystal structures\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — quantitative binding assays with deletion mutants plus structural analysis, mechanistic model supported by two orthogonal approaches\",\n      \"pmids\": [\"32241911\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TFB2M (and POLRMT) are indispensable for the maintenance of human mtDNA; knockout of TFB2M results in complete mtDNA loss, and this loss cannot be rescued by TFB1M, demonstrating TFB2M's non-redundant role in priming both strand-asynchronous and strand-coupled mtDNA replication.\",\n      \"method\": \"CRISPR/knockout of TFB2M and POLRMT in human cybrid cells; 2D agarose gel electrophoresis of replication intermediates\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined molecular phenotype (complete mtDNA loss), paralog rescue experiment as control\",\n      \"pmids\": [\"34744028\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TFAM and TFB2M localize to the nucleus of cardiac myocytes and bind directly to the Serca2 gene promoter (at -122 to -117 nt for TFB2M), regulating nuclear gene transcription; mutation of these binding sites decreases Serca2 transcription.\",\n      \"method\": \"Immunostaining (nuclear localization), chromatin immunoprecipitation (ChIP), fluorescence correlation spectroscopy, promoter mutation/reporter assays\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus functional promoter mutagenesis, single lab study\",\n      \"pmids\": [\"21113058\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"A gain-of-function variant TFB2M His264Tyr (c.790C>T) increases mitochondrial gene transcription and mitochondrial function (ATP production, membrane potential, oxygen consumption, ROS) beyond wild-type TFB2M levels; molecular dynamics simulation suggests the variant increases rigidity in the hinge region, potentially altering DNA loading/unloading.\",\n      \"method\": \"Overexpression of variant vs. wild-type TFB2M in patient fibroblasts; functional mitochondrial assays; molecular dynamics simulation\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — functional gain-of-function assay in primary cells plus computational modeling, single lab\",\n      \"pmids\": [\"30414672\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Cryo-EM structures of human mitochondrial transcription initiation complexes (IC3 and slipped-IC3) reveal that TFB2M recognizes the non-template strand via a non-template stabilizing loop (K153LDPRSGGVIKPP165) and Y209, contacting the (-1)AAA(+2) non-template sequence; TFB2M interactions with the non-template strand stabilize the transcription bubble and the -1 non-template adenine is engaged by TFB2M to facilitate initiation from +1. TFB2M is subsequently released as elongation proceeds.\",\n      \"method\": \"Cryo-EM structural determination of active initiation complexes with resolved transcription bubbles and RNA transcripts\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — cryo-EM structures of active complexes with atomic detail of TFB2M-DNA contacts\",\n      \"pmids\": [\"bio_10.1101_2024.12.02.626445\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Cryo-EM structures capturing the transition from open promoter complex to processive elongation complex reveal that TFB2M is sequentially released as the transcription complex transitions to elongation, and show new determinants of promoter specificity involving TFB2M.\",\n      \"method\": \"Cryo-EM structural series capturing multiple stages of mitochondrial transcription\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — series of cryo-EM structures capturing dynamic transitions in TFB2M engagement and release\",\n      \"pmids\": [\"bio_10.1101_2025.04.03.647028\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Knockdown of TFB2M in lung adenocarcinoma cells induces ferroptosis via a mitophagy-dependent mechanism: loss of TFB2M activates mitophagy, which degrades GPX4 (localized to mitochondria), leading to lipid peroxide accumulation and ferroptotic cell death; this was reversed by the mitophagy inhibitor Mdivi-1.\",\n      \"method\": \"siRNA knockdown, Western blot of ferroptosis/mitophagy markers, immunofluorescence co-localization of GPX4 with TOM20, ROS/lipid peroxide/Fe2+ measurements, xenograft mouse model with mitophagy inhibitor\",\n      \"journal\": \"Expert review of anticancer therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with multiple orthogonal readouts and inhibitor rescue, single lab\",\n      \"pmids\": [\"40878482\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TFB2M is an essential mitochondrial transcription initiation factor that assembles with POLRMT and TFAM on mtDNA promoters (LSP and HSP1): its non-template strand-stabilizing loop and Y209 residue contact the non-template DNA to melt the promoter from -4 to +1, while its C-terminal tail autoinhibits DNA binding until POLRMT interaction relieves this inhibition; TFB2M is non-redundant with its paralog TFB1M, is required for mtDNA maintenance (loss causes complete mtDNA depletion), and is released upon transition to processive elongation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"TFB2M is an essential mitochondrial transcription initiation factor that, together with TFAM and POLRMT, drives transcription from the LSP and HSP1 promoters of the mitochondrial genome [PMID:20410300]. TFB2M cooperates with TFAM to melt the promoter from positions -4 to +1, stabilizing the open complex via a non-template strand-stabilizing loop (K153–P165) and residue Y209 that contact the non-template DNA; its C-terminal tail autoinhibits DNA binding until relieved by interaction with POLRMT, ensuring ordered initiation complex assembly [PMID:27903899, PMID:32241911]. TFB2M is non-redundant with its paralog TFB1M: knockout causes complete mtDNA depletion, establishing that TFB2M-dependent transcription is required for priming both strand-asynchronous and strand-coupled mtDNA replication [PMID:34744028]. TFB2M expression is controlled by NRF-1/NRF-2 and the PGC-1α coactivator, linking it to the nuclear mitochondrial biogenesis program [PMID:15684387].\",\n  \"teleology\": [\n    {\n      \"year\": 2005,\n      \"claim\": \"Before TFB2M's upstream regulation was defined, it was unknown how its expression was coordinated with mitochondrial biogenesis; promoter analysis revealed that NRF-1, NRF-2, and PGC-1α/PRC coactivators directly govern TFB2M transcription, placing it within the nuclear biogenesis program.\",\n      \"evidence\": \"Promoter-reporter assays with NRF site mutagenesis and ectopic PGC-1α expression in mammalian cells\",\n      \"pmids\": [\"15684387\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether post-transcriptional regulation also tunes TFB2M protein levels\",\n        \"How TFB2M expression responds to metabolic stress signals beyond PGC-1α\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Although two TFB paralogs existed, it was unclear which was the bona fide transcription factor; reconstituted in vitro transcription demonstrated that TFB2M (not TFB1M) is the essential initiation factor that, with TFAM, increases transcription 100–200-fold from LSP and HSP1.\",\n      \"evidence\": \"Recombinant in vitro transcription with purified POLRMT, TFAM, TFB2M, and TFB1M\",\n      \"pmids\": [\"20410300\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The molecular basis for TFB1M's transcriptional inactivity despite structural similarity\",\n        \"Whether TFB2M has additional roles beyond promoter-dependent initiation\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"TFB2M was assumed to function exclusively in mitochondria; ChIP and promoter mutagenesis showed that TFB2M also localizes to the nucleus in cardiac myocytes and binds the Serca2 nuclear gene promoter to regulate its transcription.\",\n      \"evidence\": \"Immunostaining, ChIP, fluorescence correlation spectroscopy, and promoter mutation/reporter assays in cardiomyocytes\",\n      \"pmids\": [\"21113058\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether nuclear TFB2M regulates genes beyond Serca2\",\n        \"The mechanism of TFB2M nuclear import\",\n        \"Independent replication in non-cardiac cell types\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"It was unknown how the promoter was physically opened; 2-aminopurine fluorescence mapping showed that TFB2M and TFAM synergistically melt the LSP promoter from -4 to +1, with neither factor alone sufficient for full open complex formation.\",\n      \"evidence\": \"2-aminopurine fluorescence, equilibrium binding (Kd), and abortive transcription assays on reconstituted complexes\",\n      \"pmids\": [\"27903899\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Atomic details of TFB2M contacts with the melted non-template strand\",\n        \"Whether the melting mechanism differs at HSP1 versus LSP\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"A gain-of-function TFB2M variant (H264Y) demonstrated that increased TFB2M activity enhances mitochondrial gene transcription, ATP production, and oxygen consumption, linking TFB2M activity levels to mitochondrial output.\",\n      \"evidence\": \"Overexpression of H264Y versus wild-type TFB2M in patient fibroblasts with functional mitochondrial assays and molecular dynamics simulation\",\n      \"pmids\": [\"30414672\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether H264Y alters promoter melting kinetics specifically\",\n        \"Whether other naturally occurring TFB2M variants similarly affect mitochondrial function\",\n        \"Single-lab finding without independent replication\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"How TFB2M avoids premature DNA engagement was unknown; deletion mutagenesis revealed that the C-terminal tail autoinhibits DNA binding, and POLRMT relieves this autoinhibition upon complex formation, providing an ordered assembly mechanism.\",\n      \"evidence\": \"Fluorescence anisotropy DNA binding titrations with C-tail deletion mutants and structural analysis\",\n      \"pmids\": [\"32241911\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The precise POLRMT-C-tail interface at atomic resolution\",\n        \"Whether the autoinhibitory mechanism is conserved in TFB1M\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Whether TFB2M is required for mtDNA maintenance (beyond transcription) was unresolved; CRISPR knockout showed that TFB2M loss causes complete mtDNA depletion, confirming its non-redundant role in priming both modes of mtDNA replication.\",\n      \"evidence\": \"CRISPR knockout of TFB2M in human cybrid cells; 2D agarose gel electrophoresis of replication intermediates\",\n      \"pmids\": [\"34744028\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Which specific replication primer(s) require TFB2M-initiated transcripts\",\n        \"Whether partial TFB2M depletion produces intermediate mtDNA copy number phenotypes\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Cryo-EM structures resolved the atomic contacts by which TFB2M stabilizes the transcription bubble: a non-template stabilizing loop (K153–P165) and Y209 engage the non-template strand, and TFB2M is released upon transition to processive elongation.\",\n      \"evidence\": \"Cryo-EM of human mitochondrial initiation complexes (IC3, slipped-IC3) and elongation transition series (preprint)\",\n      \"pmids\": [\"bio_10.1101_2024.12.02.626445\", \"bio_10.1101_2025.04.03.647028\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structures are preprints awaiting peer review\",\n        \"Functional validation of individual loop residue contributions by mutagenesis\",\n        \"Whether TFB2M release is actively triggered or passive\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"TFB2M depletion in cancer cells was shown to trigger ferroptosis through mitophagy-dependent degradation of GPX4, revealing an unexpected link between mitochondrial transcription loss and regulated cell death.\",\n      \"evidence\": \"siRNA knockdown in lung adenocarcinoma cells with ferroptosis/mitophagy markers, GPX4 co-localization, and xenograft rescue with Mdivi-1\",\n      \"pmids\": [\"40878482\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether ferroptosis is a direct consequence of mtDNA loss or a specific TFB2M function\",\n        \"Independent replication in additional cancer types\",\n        \"Whether the GPX4 degradation mechanism generalizes beyond lung adenocarcinoma\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include the precise mechanism by which TFB2M is released during the initiation-to-elongation transition, whether TFB2M has functions beyond transcription initiation (e.g., in nuclear gene regulation), and how TFB2M variants contribute to human mitochondrial disease.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No causative Mendelian disease mutation in TFB2M has been reported\",\n        \"The structural basis for HSP1-versus-LSP promoter specificity by TFB2M is not fully resolved\",\n        \"Whether partial TFB2M deficiency produces disease phenotypes distinct from complete mtDNA depletion\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 2, 3, 5, 7]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 2, 5, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 2, 4, 6, 7]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 2, 6, 7]},\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [1, 4]}\n    ],\n    \"complexes\": [\n      \"Mitochondrial transcription initiation complex (POLRMT–TFAM–TFB2M)\"\n    ],\n    \"partners\": [\n      \"POLRMT\",\n      \"TFAM\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}